|
Originally published In Press as doi:10.1074/jbc.M104308200 on July 26, 2001
J. Biol. Chem., Vol. 276, Issue 39, 36411-36418, September 28, 2001
Functionally Separate Intracellular Ca2+ Stores in
Smooth Muscle*
Elaine R. M.
Flynn ,
Karen N.
Bradley ,
Thomas C.
Muir, and
John G.
McCarron§
From Neuroscience and Biomedical Systems, Institute of Biomedical
and Life Sciences, West Medical Bldg., University of Glasgow, Glasgow
G12 8QQ, United Kingdom
Received for publication, May 11, 2001, and in revised form, July 16, 2001
 |
ABSTRACT |
In smooth muscle, release via the inositol
1,4,5-trisphosphate (Ins(1,4,5)P3R) and
ryanodine receptors (RyR) on the sarcoplasmic reticulum (SR) controls
oscillatory and steady-state cytosolic Ca2+ concentrations
([Ca2+]c). The interplay between the two
receptors, itself determined by their organization on the SR,
establishes the time course and spatial arrangement of the
Ca2+ signal. Whether or not the receptors are co-localized
or distanced from each other on the same store or whether they exist on
separate stores will significantly affect the Ca2+ signal
produced by the SR. To date these matters remain unresolved. The
functional arrangement of the RyR and Ins(1,4,5)P3R on the SR has now been examined in isolated single voltage-clamped colonic myocytes. Depletion of the ryanodine-sensitive store, by repeated application of caffeine, in the presence of ryanodine, abolished the
response to Ins(1,4,5)P3, suggesting that
Ins(1,4,5)P3R and RyR share a common Ca2+
store. Ca2+ release from the Ins(1,4,5)P3R did
not activate Ca2+-induced Ca2+ release at the
RyR. Depletion of the Ins(1,4,5)P3-sensitive store, by the
removal of external Ca2+, on the other hand, caused only a
small decrease (~26%) in caffeine-evoked Ca2+
transients, suggesting that not all RyR exist on the common store shared with Ins(1,4,5)P3R. Dependence of the stores on
external Ca2+ for replenishment also differed; removal of
external Ca2+ depleted the
Ins(1,4,5)P3-sensitive store but caused only a slight reduction in caffeine-evoked transients mediated at RyR. Different mechanisms are presumably responsible for the refilling of each store.
Refilling of both Ins(1,4,5)P3-sensitive and
caffeine-sensitive Ca2+ stores was inhibited by each of the
SR Ca2+ ATPase inhibitors thapsigargin and cyclopiazonic
acid. These results may be explained by the existence of two
functionally distinct Ca2+ stores; the first expressing
only RyR and refilled from [Ca2+]c, the second
expressing both Ins(1,4,5)P3R and RyR and dependent upon
external Ca2+ for refilling.
 |
INTRODUCTION |
Release of Ca2+ from the sarcoplasmic reticulum
(SR)1 store, a mechanism that
regulates smooth muscle contractile activity, involves the
participation of two receptor/channel complexes, the ryanodine receptor
(RyR) and the inositol 1,4,5-trisphosphate receptor
(Ins(1,4,5)P3R). Release from this store regulates the bulk
average [Ca2+]c both directly (1) and indirectly
either via modulation of the plasmalemmal membrane potential (2) or by
activation of store-operated Ca2+ entry (3). The magnitude,
time course, and frequency of the SR Ca2+ signal depend on
the functional interaction, localization, and arrangement of the
Ins(1,4,5)P3R and RyR on the SR store(s).
Although, morphologically, the SR appears as an interconnected network
of tubules (4, 5), it may adopt different configurations within the
cell and components may detach and reattach thereby influencing the
pattern and distribution of the RyR and Ins(1,4,5)P3R (6,
7). In Purkinje neurons, for example,
Ins(1,4,5)P3R-expressing regions may detach from other
internal store elements (8, 9). Indeed, different Ca2+
concentrations have been found within the lumen of the SR (10) suggesting that discontinuities may exist within the structures surrounding the lumen itself. This provides a morphological basis for
the existence of various arrangements of Ca2+ stores.
The SR Ca2+ stores in smooth muscle are classified on the
basis of the arrangement of Ins(1,4,5)P3R and RyR; yet
conflicting evidence exists regarding their number. A single store,
containing both RyR and Ins(1,4,5)P3R, has been proposed,
based on the observation that caffeine (which activates RyR) prevented
Ins(1,4,5)P3-mediated Ca2+ release
(e.g. 11-16). Two separate Ca2+ stores have
also been proposed, one that expresses only RyR, the other only
Ins(1,4,5)P3R. In support of this latter view, depletion of
the RyR-sensitive store failed to abolish agonist-evoked Ins(1,4,5)P3-mediated Ca2+ release and vice
versa (17). More elaborate arrangements of SR Ca2+ stores
have also been proposed. In some smooth muscles (e.g. taenia
coli, pulmonary artery, myometrium) one store may express both RyR and
Ins(1,4,5)P3R, whereas a second, in the same cell, may
express Ins(1,4,5)P3R alone (18-20). Conversely, one store expressing both RyR and Ins(1,4,5)P3R and a second separate
store RyR alone have also been suggested (21).
Further support for the existence of two separate stores has come from
studies on the response of each of the receptors to inhibitors of the
SR Ca2+ pump, thapsigargin and cyclopiazonic acid (CPA),
each of which depletes the stores of Ca2+. Differences in
the sensitivity to the pump inhibitors of the Ca2+ release
evoked by either caffeine or Ins(1,4,5)P3 have been
interpreted as evidence for the existence of separate stores for each
receptor (5, 16, 22). For example, in arterial myocytes the
ryanodine/caffeine-sensitive store was not sensitive to either
thapsigargin or CPA, whereas the Ins(1,4,5)P3-sensitive
Ca2+ store was depleted by each (16, 22). The situation has
been complicated further by the proposed existence in murine bladder smooth muscle cells (23) of three Ca2+ stores, one
containing RyR and Ins(1,4,5)P3R, another expressing only
Ins(1,4,5)P3R, and a third containing only RyR.
Whereas the proposed arrangements of RyR and
Ins(1,4,5)P3R may reflect the complexity of the underlying
biology, differences in experimental approaches may also have
contributed to the variety of views expressed. For example, caffeine,
commonly used to activate RyR, also inhibits Ins(1,4,5)P3R
(24, 25). In some studies (e.g. 12, 21) caffeine remained
present while an Ins(1,4,5)P3-generating agonist was
applied. Invariably, such experiments demonstrated an inhibition of the
Ins(1,4,5)P3-mediated response and the results have been
taken as evidence for the existence of a common Ca2+ store.
Inhibition of the Ins(1,4,5)P3 receptor by caffeine, rather than depletion of a common store, could have accounted for the absence
of response to an Ins(1,4,5)P3-generating agonist.
Additional difficulties in the classification of SR Ca2+
stores, i.e. their location and number, have followed the
use of plasmalemmal agonists and the multiple, yet separate,
biochemical pathways so activated. Two particular aspects of such
difficulties are evident. First, when membrane currents are used as
indicators of [Ca2+]c, agonists may modify these
currents independently of SR Ca2+ release (e.g.
28, 29). Second, regulation of the RyR and Ins(1,4,5)P3R by
Ca2+ derived from agonist activation of several different
biochemical pathways may occur with misleading consequences. For
example, in rabbit portal vein, depletion of the
Ins(1,4,5)P3-sensitive store, by norepinephrine, abolished
the response to caffeine (which acts on the RyR (27)), consistent with
both receptors residing on a common Ca2+ store. On the
other hand, Ca2+ released from the SR via
Ins(1,4,5)P3R activation may have triggered a regenerative
Ca2+-induced Ca2+ release (CICR) at the RyR
(11, 28), which could have amplified the
Ins(1,4,5)P3-evoked Ca2+ transient. If so, two
outcomes could be anticipated (a) the continued presence of
Ins(1,4,5)P3 could deplete the RyR-sensitive
Ca2+ pool; (b) depletion of the RyR-sensitive
Ca2+ pool would reduce the response to
Ins(1,4,5)P3. Either of these results could be
misinterpreted as support for the existence of a common
Ca2+ store.
Notwithstanding these difficulties, it is important to determine the
arrangement of Ca2+ stores in smooth muscle to help clarify
the precise mechanisms of Ca2+ release, a vital ingredient
in our understanding of contractility. This problem has been addressed
in the current investigation by seeking answers to the following
questions: 1) Are Ins(1,4,5)P3R and RyR present on the same
store or on separate stores of the SR? 2) Does Ca2+
released from the Ins(1,4,5)P3-sensitive store trigger CICR
via activation of the RyR? 3) Are there differences between the
refilling mechanisms of Ins(1,4,5)P3-sensitive and
ryanodine-sensitive intracellular Ca2+ stores? In this
study freshly isolated single smooth muscle cells rather than
multicellular preparations were used, removing the difficulty of there
being different store characteristics existing in different cells or of
store reorganization, which may accompany the use of cell culture
preparations. Ca2+ influx was controlled under voltage
clamp conditions and directly measured in this investigation. Flash
photolysis of caged Ins(1,4,5)P3 (Ins(1,4,5)P3) and caffeine were each used to
minimize activation of second messenger systems so that a clearer
understanding of the control of Ca2+ release from the
receptors could be obtained. From the results of the present study it
is proposed that two functionally distinct SR Ca2+ stores
exist in colonic myocytes; one expressing both
Ins(1,4,5)P3R and RyR and dependent upon an external
Ca2+ source for replenishment and a second store containing
only RyR, which can be refilled form [Ca2+]c.
 |
EXPERIMENTAL PROCEDURES |
Cell Isolation--
From male guinea pigs (500-700 g) stunned
by a blow to the head and immediately killed by exsanguination, a
segment of distal colon (~5 cm) was removed. The circular muscle was
separated from the longitudinal layer, and single cells were prepared
from the former using a two-step enzymatic process (30), stored at
4 °C, and used the same day.
Membrane Current Recording--
Cells were voltage-clamped in
the dialyzed whole cell configuration. Currents were amplified by an
Axopatch 1D (Axon Instruments, Union City, CA), low pass filtered at
500 Hz (8-pole Bessel filter, Frequency Devices, Haverhill, MA), and
digitally sampled at 1.5 kHz using a Digidata interface, pCLAMP
software (version 6.0.1, Axon Instruments), and Axotape (Axon
Instruments) and stored for analysis. Cells were held at a membrane
potential (Vm) of 70 mV unless otherwise
indicated. The bathing solution contained (mM): sodium
glutamate, 80; NaCl, 40; tetraethylammonium chloride, 20;
MgCl2, 1.1; CaCl2, 3; HEPES, 10; and
D-glucose, 30; pH 7.4 adjusted with NaOH. The
Ca2+-free bathing solution contained MgCl2 (3 mM) and EGTA (1 mM). The pipette solution
contained (mM): Cs2SO4, 85; CsCl,
20; MgCl2, 1; MgATP, 3; pyruvic acid, 2.5; malic acid, 2.5;
NaH2PO4, 1; creatine phosphate, 5; GTP, 0.5;
HEPES, 30; fluo-3 penta-ammonium salt, 0.1; caged
Ins(1,4,5)P3, 0.025; pH 7.2 adjusted with CsOH. The access
afforded by the whole cell patch electrode allowed entry into the cell
of the membrane-impermeant fluo-3 and caged
Ins(1,4,5)P3.
Cytosolic Ca2+ Concentration
([Ca2+]c)
Measurement--
[Ca2+]c was measured using the
membrane-impermeable fluo-3 (penta-ammonium salt). Fluorescence
measurements were made using a microfluorometer consisting of an
inverted fluorescence microscope (Nikon Diaphot) and a
photomultiplier tube with a bi-alkali photocathode. Fluo-3 was excited
at 488 nm (bandpass 9 nm) from a PTI Delta Scan (Photon Technology
International Inc., East Sheen, London, UK) through the
epi-illumination port of the microscope (using one arm of a bifurcated
quartz fiber optic bundle). Excitation light was passed through a field
stop diaphragm, to reduce background fluorescence, and reflected off a
505-nm long-pass dichroic mirror; emitted light was guided through a
535-nm barrier filter (bandpass 35 nm) to a photomultiplier in
photon-counting mode. Longer wavelengths, from bright field
illumination with a 610-nm Shott glass filter, were reflected onto a
charge-coupled device camera (Sony model XC-75) mounted onto the
viewing port of the Delta Scan thus allowing the cell to be monitored
during experiments. Interference filters and dichroic mirrors were
obtained from Glen Spectra (London, UK). To photolyze caged
Ins(1,4,5)P3 the output of a xenon flashlamp (Rapp
OptoElektronic, Hamburg, Germany) was passed though a UG-5 filter to
select ultraviolet light and merged into the excitation light path of
the microfluorometer using the second arm of the quartz bifurcated
fiber optic bundle. The nominal flash lamp energy was 57 mJ, measured
at the output of the fiber optic bundle. The flash duration was about 1 ms.
Caffeine (10 mM) was applied by hydrostatic pressure
(Pneumatic PicoPump PV820, World Precision Instruments, Inc., Sarasota, FL). All experiments were carried out at room temperature
(18-22 °C), and drugs were applied either hydrostatically via a
pipette or into the bathing solution as indicated in the text.
Data Analysis--
Changes in cytosolic Ca2+ were
expressed as a ratio (F/Fo) of the
fluorescence counts (F) relative to baseline counts before stimulation (Fo).
F/Fo indicates the magnitude of
the change in F/Fo at the peak of the
evoked transient relative to the baseline ratio. Original fluorescence
records were not filtered, smoothed, or averaged. Background
fluorescence was not subtracted. Statistical analyses were performed
using either Mann-Whitney tests (on normalized data) or paired
Student's t tests (on raw data). Summarized data are shown
as means ± S.E. and taken to be statistically significant when
p < 0.05. n indicates numbers of cells used.
Drugs and Reagents--
fluo-3 penta-ammonium salt was obtained
from Molecular Probes, Inc. (Eugene, OR). Caged
Ins(1,4,5)P3 trisodium salt, thapsigargin, cyclopiazonic
acid (CPA), and ryanodine were obtained from Calbiochem-Novabiochem Ltd. Thapsigargin, forskolin CPA, and ryanodine were each dissolved in
dimethyl sulfoxide, to give a final bath concentration <0.1% dimethyl
sulfoxide. Ca2+-free Eagle's minimum essential spinner
medium was purchased from Life Technologies, Inc. (Paisley, UK). Papain
and collagenase were obtained from Sigma Chemical Co., UK or
Worthington Biochemical Corp. (Lakewood, NJ). All other reagents were
purchased from Sigma, UK (Poole, UK).
 |
RESULTS |
Depolarization from a membrane potential (Vm)
of 70 mV to 0 mV (Fig. 1C)
activated a voltage-dependent Ca2+ current
averaging 160 ± 18 pA (Fig. 1D) and a transient
increase in [Ca2+]c, which averaged 1.83 ± 0.15 F/Fo units above baseline ( F/Fo; n = 59;
p < 0.001;Fig. 1A). Flash photolysis of
caged Ins(1,4,5)P3 (Ins(1,4,5)P3,
upward-pointing arrows) increased [Ca2+]c by an average of 2.26 ± 0.19 F/Fo (n = 59;
p < 0.001; Fig. 1A). Caffeine (Fig.
1B) elevated [Ca2+]c by 2.05 ± 0.18 F/Fo (n = 59;
p < 0.001) through activation of RyR.
Ins(1,4,5)P3 and caffeine each evoked reproducible
increases in [Ca2+]c when applied at ~50-s
intervals.

View larger version (16K):
[in this window]
[in a new window]
|
Fig. 1.
Ca2+ influx,
InsP(1,4,5)P3, and caffeine each increased
[Ca2+]c. Depolarization from a membrane
potential (Vm) of 70 mV to 0 mV (C) activated a
voltage-dependent Ca2+ current (D, and on an
expanded time base in E) and elevated [Ca2+]c
(A). Ins(1,4,5)P3 ( 's in this and following
figures) also produced approximately reproducible increases in
[Ca2+]c (A), as did caffeine (caff.;
B).
|
|
Are All InsP(1,4,5)P3 Receptors Present on the
Ca2+ Store Containing RyR?--
To test this, the response
to Ins(1,4,5)P3, following depletion of the
ryanodine-sensitive store by caffeine, was examined. At 70 mV,
Ins(1,4,5)P3 evoked approximately reproducible increases in
[Ca2+]c (3.28 ± 0.35 F/Fo; n = 5; Fig.
2, A and B) as did caffeine (Fig. 2C, 3.12 ± 0.2 F/Fo, n = 5, Fig.
2, A and B). Caffeine-evoked Ca2+
transients were inhibited to 6 ± 3% of controls by ryanodine (50 µM; 0.14 ± 0.08 F/Fo; n = 5;
p < 0.001). Significantly, after this inhibition of
the caffeine-evoked Ca2+ transient, the
Ins(1,4,5)P3-evoked Ca2+ transient was reduced
to 7 ± 2% of control values (0.19 ± 0.04 F/Fo; n = 5;
p < 0.001; Fig. 2). These results are compatible with
the view that Ins(1,4,5)P3R and RyR exist on a common SR Ca2+ store.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
Depletion of the caffeine-sensitive store
inhibited the response to InsP(1,4,5)P3.
Ins(1,4,5)P3 ( ) and caffeine (C) each
produced reproducible rises in [Ca2+]c
(A and B). In the presence of ryanodine (50 µM) the response to caffeine (C) decreased
(A and B) as did the response to
Ins(1,4,5)P3 ( ; A and B). Summary
data from five cells are shown in A. *, significant
inhibition of the Ins(1,4,5)P3-evoked Ca2+
transient; **, significant inhibition of the caffeine-evoked
Ca2+ transient. 1st, 2nd, etc. refers
to the order of responses after treatment in this and other
figures.
|
|
Does CICR from the RyR Contribute to the
InsP(1,4,5)P3-evoked Ca2+ Transient?--
If
on the other hand two separate stores exist, i.e. one for
Ins(1,4,5)P3R and another for RyR, release of a small
amount of Ca2+ from the Ins(1,4,5)P3-sensitive
store could trigger a further, larger release of Ca2+ from
the separate ryanodine-sensitive store by CICR. If so, depletion of the
ryanodine-sensitive store, by caffeine and ryanodine, would reduce the
Ins(1,4,5)P3-evoked response. If Ca2+, released
through the Ins(1,4,5)P3R, triggered CICR at the RyR, ryanodine alone would reduce Ins(1,4,5)P3-evoked
Ca2+ transients. This was not observed (Fig.
3). Ins(1,4,5)P3 evoked reproducible increases in [Ca2+]c of similar
magnitude in the presence (50 µM) and absence of
ryanodine (n = 5, Fig. 3, Vm = 70
mV). Thus Ca2+ released by Ins(1,4,5)P3 did not
subsequently trigger CICR from the RyR, and this provides further
evidence for the existence of a common Ca2+ store. In other
investigations, reduction, by ryanodine, of the Ca2+
transient evoked by Ins(1,4,5)P3-generating agents was
interpreted as evidence that Ins(1,4,5)P3-evoked
Ca2+ activates CICR at the RyR (11, 28). The plasmalemma
agonists used in these experiments to generate Ins(1,4,5)P3
could also have activated other second messengers that in turn
sensitized the RyR to Ca2+ enabling
Ins(1,4,5)P3-evoked Ca2+ release to activate
CICR at the RyR. Alternatively, Ca2+ release from the SR
store may activate further Ca2+ release under conditions of
"store overload" (31, 32). Such store overload conditions
could conceivably arise in some smooth muscle types, facilitating
CICR.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
Ca2+ released through
InsP(1,4,5)P3 receptors did not activate RyR.
Ins(1,4,5)P3 ( ) produced reproducible increases in
[Ca2+]c (A and B).
Ryanodine (50 µM) did not significantly alter the
magnitude of Ins(1,4,5)P3-evoked transients, which averaged
1.98 ± 0.37 F/Fo before and
2.02 ± 0.44 F/Fo after
ryanodine (n = 5; p > 0.05).
A, summarizes data from five cells (mean ± S.E.).
|
|
To ensure that the absence of an Ins(1,4,5)P3-evoked
Ca2+ transient following depletion of the
ryanodine/caffeine-sensitive store (Fig. 2) was due neither to
inactivation of the Ins(1,4,5)P3R by caffeine (24, 25) nor
to allocation of an inadequate period for store refilling after
caffeine, the time course of recovery of the response to
Ins(1,4,5)P3 after caffeine was examined at 70 mV. The
magnitude of the Ins(1,4,5)P3-evoked transient was reduced
to 3 ± 1% 10 s after caffeine (n = 5; Fig.
4, A and G). Recovery was time-dependent; 50 s after exposure to
caffeine the Ins(1,4,5)P3-evoked Ca2+ transient
had returned to 92 ± 5% of controls (n = 6; Fig.
4, E and G). These results suggest that, at the
time intervals used (50-60 s), neither inactivation of the
Ins(1,4,5)P3R by caffeine nor an insufficient time period
for store refilling accounted for the inhibition of the
Ins(1,4,5)P3-evoked Ca2+ transient by caffeine
and ryanodine (Fig. 2). Collectively, the data (Figs. 2, 3, and 4)
suggest that all Ins(1,4,5)P3R exist on a store that also
contains RyR.

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
Time dependence of the recovery of the
InsP(1,4,5)P3-evoked Ca2+ transient after
caffeine. The magnitude of the Ins(1,4,5)P3-evoked
( ) Ca2+ transient was virtually abolished 10 s
after caffeine (A) from 1.89 ± 0.72 F/Fo to 0.06 ± 0.04 F/Fo, (p < 0.05, n = 5). Recovery of the response to
Ins(1,4,5)P3 was time-dependent
(A-F). The amplitude of the Ins(1,4,5)P3-evoked
transient had fully recovered to 3.01 ± 0.9 F/Fo compared with 3.37 ± 1.07 F/Fo before caffeine
(p > 0.05; n = 6) 50 s after
caffeine (F). The amplitude of both
Ins(1,4,5)P3- and caffeine-evoked transients also increased
proportionately with time, presumably as the SR Ca2+
content increased. G shows summary data from six identical
experiments showing the time course of recovery of the
Ins(1,4,5)P3-evoked Ca2+ transient after
caffeine. *, significant inhibition of the
Ins(1,4,5)P3-evoked transient (p < 0.05).
|
|
Not All RyR Are Present on the Store, Which Contains
InsP(1,4,5)P3R--
To determine whether or not all
RyR were present on the store that contained Ins(1,4,5)P3R,
the Ins(1,4,5)P3-sensitive store was depleted by removal of
external Ca2+ and the ability of caffeine to activate the
RyR and evoke a Ca2+ transient was examined. Refilling of
the Ins(1,4,5)P3-sensitive store is dependent on external
Ca2+ (33), and removing it reduced the response to
Ins(1,4,5)P3 to 5 ± 2% of controls
(n = 6; p < 0.05;
Vm = 70 mV, Fig. 5).
However, after the almost complete loss of the
Ins(1,4,5)P3-evoked transient, caffeine evoked a
Ca2+ transient that averaged 74 ± 25% of control
values (n = 6; p < 0.05; Fig. 5).
These results are consistent with there being a second separate
Ca2+ store that contains only RyR.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 5.
Depletion of the
InsP(1,4,5)P3-sensitive store reduced but did not abolish
the response to caffeine. Ins(1,4,5)P3 ( ) and
caffeine (C) each evoked approximately reproducible
increases in [Ca2+]c (A and
B; Vm = 70 mV). Removal of external
Ca2+ (and addition of 1 mM EGTA) reduced the
Ins(1,4,5)P3-evoked Ca2+ transient to 5 ± 2% of controls after five UV flashes (from 1.91 ± 0.11 F/Fo to 0.08 ± 0.02 F/Fo; n = 6;
p < 0.05). Following depletion of the
Ins(1,4,5)P3-sensitive store, caffeine (caff.;
C) produced a Ca2+ transient that averaged
74 ± 25% of the control amplitude (1.18 ± 0.4 F/Fo compared with 1.57 ± 0.13 F/Fo prior to depletion of
the Ins(1,4,5)P3-sensitive store; n = 6;
p < 0.05). Data from six cells are summarized in
A; *, significant inhibition of the
Ins(1,4,5)P3-evoked Ca2+ transient; **,
significant inhibition of the caffeine-evoked Ca2+
transient.
|
|
Refilling of the Ca2+ Stores--
The above results
(Fig. 5) raised the possibility that the degree of dependence of the
two stores on external Ca2+ for Ca2+ release
may differ. This was examined following withdrawal of external
Ca2+ by investigating the refilling of the RyR- and
Ins(1,4,5)P3-sensitive stores after either caffeine or
Ins(1,4,5)P3. The caffeine-evoked Ca2+
transient (via RyR; Fig. 6A)
was reduced, on average, to some 87 ± 9% of controls
(n = 5; p = 0.5; Fig. 6, A
and B). In contrast, the Ins(1,4,5)P3-evoked
Ca2+ transient (acting through Ins(1,4,5)P3R)
was reduced to 6 ± 2% of controls (Fig. 6B; see Fig.
5). These results suggest that, unlike the situation with the
Ins(1,4,5)P3-sensitive Ca2+ store (Fig. 5),
Ca2+ release from the RyR by caffeine may be recycled so
that refilling is largely independent of external Ca2+.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 6.
The amplitude of the caffeine-evoked response
was reduced but not abolished in the absence of external
Ca2+. Caffeine (caff.; A
(iii)) produced reproducible increases in cytosolic
Ca2+ (A (ii)). Removal of external
Ca2+ reduced but did not abolish the amplitude of the
caffeine-evoked response (3.35 ± 0.47 F/Fo compared with 2.89 ± 0.47 F/Fo; n = 5;
p = 0.5). A (i), summary data
from five cells (mean ± S.E.). In comparison, refilling of the
Ins(1,4,5)P3 ( )-sensitive store was prevented following
removal of external Ca2+ (B; from
1.81 ± 0.13 to 0.09 ± 0.02 F/Fo; n = 7;
p < 0.05). B (i) (summary data
from seven cells) demonstrates that the amplitude of the
Ins(1,4,5)P3-evoked Ca2+ transient
(B (ii)) was inhibited (mean ± S.E.). Note
the different time bars in A and
B.
|
|
Effects of Elevation of cAMP on InsP(1,4,5)P3-evoked
Ca2+ Transients--
Caffeine inhibits phosphodiesterase
activity and so may elevate the intracellular concentration of cAMP
([cAMP]c) (34). The persistence of the store Ca2+
content, in the absence of external Ca2+, as indicated by
the maintained amplitude of the caffeine-evoked Ca2+
transient, could have arisen from stimulation of SERCA by an elevated
[cAMP]c due to caffeine (35) rather than to a difference in
the refilling mechanism. To examine this possibility, dependence of
Ins(1,4,5)P3 store refilling on external Ca2+
was examined when [cAMP]c had been increased (a)
by the phosphodiesterase inhibitor IBMX (500 µM) and
(b) by forskolin (1 µM), which stimulates
adenylate cyclase thereby raising [cAMP]c. In the absence of
either drug, Ins(1,4,5)P3-evoked Ca2+
transients of approximately reproducible amplitude that averaged 1.89 ± 0.12 F/Fo
(n = 6). Following incubation (10 min) with either IBMX
or forskolin, Ins(1,4,5)P3-evoked transients of
approximately reproducible amplitude (2.18 ± 0.67 F/Fo; n = 6; Fig.
7, for IBMX), which were not
significantly different from controls. Upon removal of external
Ca2+, in the continued presence of either IBMX or
forskolin, repeated application of Ins(1,4,5)P3 depleted
the Ins(1,4,5)P3-sensitive store as evidenced by the
decline in the amplitude of the Ca2+ transient. With IBMX,
after the fourth Ins(1,4,5)P3 challenge, the
Ca2+ increase averaged 15 ± 3% of the
Ins(1,4,5)P3-evoked Ca2+ transients observed in
IBMX in the presence of external Ca2+ (0.56 ± 0.31 F/Fo; p < 0.01;
n = 6; Fig. 7). Qualitatively similar results were
obtained with forskolin. Removal of external Ca2+ again
inhibited the amplitude of the Ins(1,4,5)P3-evoked
transient significantly to 8 ± 3% of controls (p < 0.05 by Mann-Whitney test; data not shown; Vm = 70 mV). In these same cells only 3 ± 2% of the
Ins(1,4,5)P3-evoked transient remained in the presence of
forskolin (1 µM) following the removal of external Ca2+ (n = 3; p < 0.05 by
Mann-Whitney test). Together the results with IBMX and forskolin
indicated that elevation of [cAMP]c is unlikely to offset the
effect of external Ca2+ withdrawal on store content.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 7.
Elevated [cAMP]c does not maintain
SR store Ca2+ content in the absence of external
Ca2+. Ins(1,4,5)P3 ( ) produced
approximately consistent increases in [Ca2+]c
(A and B). IBMX (500 µM) did not
significantly alter the magnitude of the
Ins(1,4,5)P3-evoked Ca2+ transients
(p > 0.05). The break in the record (//) indicates an
interval of 6 min to allow IBMX to take effect. Removal of external
Ca2+ inhibited the response to Ins(1,4,5)P3,
such that upon the fourth challenge with Ins(1,4,5)P3, the
evoked Ca2+ was 15 ± 3% of control values
(p < 0.05). Summary data (mean ± S.E.) from six
cells (A) showed that IBMX did not maintain
Ins(1,4,5)P3-evoked Ca2+ transients in the
absence of external Ca2+.
|
|
Effects of SR Ca2+ Pump
Inhibitors--
Ca2+ stores have been differentiated on
the basis of their sensitivity to the SERCA inhibitors cyclopiazonic
acid (CPA) and thapsigargin (5, 36, 37). The ability of CPA and
thapsigargin to each inhibit Ins(1,4,5)P3- and
caffeine-evoked Ca2+ transients was therefore examined.
Cells were once again held at a membrane potential of 70 mV.
Ins(1,4,5)P3 and caffeine (Fig. 8, C and F) each
produced reproducible increases in [Ca2+]c at
~50-s intervals (Fig. 8, B and E). Thapsigargin (500 nM) increased resting [Ca2+]c
from 1.07 ± 0.05 F/Fo to
1.73 ± 0.12 F/Fo after 5 min
(n = 10; p < 0.001; Fig.
8B), and inhibited the responses to both
Ins(1,4,5)P3 and caffeine (Fig. 8 A and
B). Ins(1,4,5)P3-evoked Ca2+
transients were reduced, from an average of 4.19 ± 0.40 F/Fo in control to 0.23 ± 0.06 F/Fo in the presence of
thapsigargin (n = 10; p < 0.001; Fig.
8A). The caffeine-evoked Ca2+ transient was also
reduced from 3.81 ± 1.38 F/Fo in control to 0.04 ± 0.06 F/Fo in the presence of
thapsigargin (n = 10; p < 0.001; Fig.
8A). CPA (10 µM) also increased resting
[Ca2+]c from 1.18 ± 0.09 F/Fo immediately prior to CPA to 1.46 ± 0.11 F/Fo after 5 min in
the drug (n = 16; p < 0.001; Fig. 8E). CPA inhibited both the Ins(1,4,5)P3-evoked
and caffeine-evoked Ca2+ transients (Fig. 8, D
and E). On average, the response to Ins(1,4,5)P3 was reduced from 1.70 ± 0.32 F/Fo to 0.09 ± 0.04 F/Fo in CPA (n = 16; p < 0.001; Fig. 8D) and that to
caffeine from 1.65 ± 0.34 F/Fo to 0.07 ± 0.06 F/Fo (n = 16;
p < 0.001; Fig. 8D). Thus, refilling of
both the Ins(1,4,5)P3-sensitive and caffeine-sensitive stores is prevented by each of the SERCA inhibitors thapsigargin and
CPA; use of SERCA inhibitors is unlikely to be of value in differentiating between Ca2+ stores in these cells.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 8.
Thapsigargin and CPA each inhibited the
refilling of both InsP(1,4,5)P3-sensitive and
caffeine-sensitive Ca2+ stores.
Ins(1,4,5)P3 ( ) and caffeine (C and
F) each produced Ca2+ transients of
approximately consistent amplitude (A, B and
D, E). Thapsigargin (500 nM;
A-C) and CPA (10 µM; D-F) each
elevated resting [Ca2+]c and inhibited both the
Ins(1,4,5)P3-evoked and caffeine-evoked Ca2+
transients (n = 10 and n = 16, respectively). Summary data showing the mean ± S.E. of
Ins(1,4,5)P3-evoked and caffeine-evoked Ca2+
transients, and their inhibition by thapsigargin and CPA, is summarized
in A and D, respectively. *, significant
inhibition of the Ins(1,4,5)P3-evoked Ca2+
transient; **, significant inhibition of the caffeine-evoked
Ca2+ transient compared with control values
(p < 0.05).
|
|
 |
DISCUSSION |
Ca2+ release from and uptake into internal SR
Ca2+ stores plays a central role in the activity of most
cells, including that of excitation-contraction coupling in smooth
muscle. Although it is conceded that release occurs via
Ins(1,4,5)P3R and RyR, the interrelationship between these
two receptors in their access to stored Ca2+ is unclear. A
diversity of store and receptor arrangements has been proposed. This
study has demonstrated the presence of two Ca2+ stores in
colonic smooth muscle, one expressing both Ins(1,4,5)P3R and RyR the other only RyR. Support for this view comes from two key
observations in which the stores accessed by either
Ins(1,4,5)P3R or RyR were depleted of Ca2+.
First, the store accessed by RyR was depleted of Ca2+ (by
repetitive activation with caffeine in the presence of ryanodine to
maintain the RyR in the open state), and under these circumstances the
response to Ins(1,4,5)P3 was virtually abolished. Second, when the store accessed by Ins(1,4,5)P3R was depleted, by
withdrawal of external Ca2+, and the
Ins(1,4,5)P3 response was effectively abolished,
significantly, the Ca2+ response to RyR activation by
caffeine persisted. The observation that the
Ins(1,4,5)P3-evoked Ca2+ response was almost
abolished after caffeine (in the presence of ryanodine) could not be
attributed to inhibition of an amplification of the
Ins(1,4,5)P3-evoked response by CICR, because
Ins(1,4,5)P3-evoked Ca2+ release did not
activate this mechanism. Nor could the observation be explained by
inactivation of the Ins(1,4,5)P3R by caffeine because the
Ins(1,4,5)P3-evoked Ca2+ transient had fully
recovered at the time intervals between application of caffeine and
Ins(1,4,5)P3 used in the present study. Finally, the
results of the present study demonstrated differences in the refilling
mechanisms of the two stores. The store expressing both Ins(1,4,5)P3R and RyR was dependent on external
Ca2+ for replenishment whereas the store with only RyR was not.
The precise number and arrangement of Ca2+ stores, among
different cell types, is a matter of debate. In cerebellar Purkinje neurons, as in the present study, ryanodine inhibited the
Ins(1,4,5)P3-evoked Ca2+ transient, in keeping
with the view that both Ins(1,4,5)P3R and RyR were present
on a common store. However, whether or not an additional separate store
with only RyR involved was not determined (38). One store with both
Ins(1,4,5)P3R and RyR and an additional separate store,
with only RyR similar to the present view, have also been proposed in
vascular smooth muscle (21). Other studies had initially raised the
possibility of there being two stores but with different receptor
arrangements from those presently proposed. For example, from
experiments in smooth muscle, of the two Ca2+ stores
proposed, one contained both RyR and Ins(1,4,5)P3R, the other only Ins(1,4,5)P3R (19, 20). Alternatively, separate stores have been proposed for both RyR and Ins(1,4,5)P3
receptors (e.g. 39-41). A commonly employed method with
which to study the receptors on the Ca2+ stores has been to
inhibit store Ca2+ pumps by thapsigargin or cyclopiazonic
acid (CPA) and to observe the responses to activation of
Ins(1,4,5)P3R and RyR. In various cell types, thapsigargin
and CPA each abolished Ca2+ release in response to
activation of either RyR or Ins(1,4,5)P3R but not to
activation of both. This supported the idea of there being more than
one store (36, 37, 42-44). Studies in smooth muscle and astrocytes
suggested that, despite an apparently uniform Ca2+ content
throughout most of the store, CPA and the RyR activator caffeine
released Ca2+ from seemingly separate compartments (5, 22),
i.e. there were in effect two stores. However, the
relationship between SR Ca2+ pumps on the one hand and the
Ins(1,4,5)P3R and RyR on the other could not be presently
differentiated by the use of Ca2+ pump inhibitors. SR
Ca2+ pumps presumably on both the common
Ins(1,4,5)P3R/RyR store and the RyR-only store were each
inhibited by thapsigargin and CPA (see also 45, 46). Differences in the
sensitivity of the Ca2+ pumps on the internal SR
Ca2+ store to the inhibitors (47, 48), which may also vary
among different tissues, were presumably responsible for these observations.
Differences in SR Luminal Ca2+ Regulation of the
Receptors Does Not Account for the Differences in Response to
InsP(1,4,5)P3 and Caffeine--
On the basis of the
two-store system proposed, the observation that a substantial
caffeine-evoked Ca2+ transient persisted, after depletion
of the Ins(1,4,5)P3-sensitive store, could be explained if
the opening of the Ins(1,4,5)P3R and RyR was each regulated
differently by the SR luminal Ca2+ concentration (49-52).
Thus, as luminal Ca2+ decreased, the
Ins(1,4,5)P3 sensitivity to Ins(1,4,5)P3 could have diminished and the receptor could no longer be able to release Ca2+, even though the SR itself had not been depleted. The
sensitivity of the RyR to caffeine could have been affected to a lesser
degree than that of the Ins(1,4,5)P3R by decreases in
luminal Ca2+, and caffeine could have remained effective in
evoking Ca2+ release. However, if a single common store for
both Ins(1,4,5)P3R and RyR existed (rather than the
presently proposed two stores), luminal regulation of the receptors
with the accompanying differences in sensitivity between RyR and
Ins(1,4,5)P3R could also serve as a model in which the SR
could function, in effect, as two stores. If luminal regulation was to
account for the present results, a 25% decrease in the SR
Ca2+ content would be sufficient to prevent
Ca2+ release via the Ins(1,4,5)P3R,
significantly different from previously published values (70-95%
(53-55)). This arises from the observation that some 75% of the
Ca2+ transient evoked by caffeine persisted when the
Ins(1,4,5)P3-evoked transient was abolished. SR luminal
Ca2+ regulation of the Ins(1,4,5)P3R thus seems
unlikely to account for the present observations. Nor is luminal
regulation responsible for differences between the two stores in
their dependence upon external Ca2+ for replenishment. Thus
the response to caffeine is maintained whereas that to
Ins(1,4,5)P3 disappears after the removal of external Ca2+. Together, these findings support the presence of two
discrete SR Ca2+ stores; one able to refill from
[Ca2+]c, the other from extracellular
Ca2+ entry.
Mechanisms of Store Refilling--
Depletion of
Ins(1,4,5)P3-sensitive stores in all cell types so far
examined activates a store-operated Ca2+ entry pathway,
which is necessary for its replenishment (reviewed in Refs. 56-58) as
is depletion of the ryanodine-sensitive store, although not in all cell
types (59-63). In the present study, replenishment of the store
containing RyR alone did not require external Ca2+,
suggesting that plasmalemmal store-operated Ca2+ entry is
unnecessary for the maintenance of the Ca2+ content of this
store. In the store containing both RyR and Ins(1,4,5)P3R, on the other hand, external Ca2+ entry, presumably via
store-operated channels, is essential for store refilling in colonic
myocytes (33). Perhaps differences in store location within the cell
determines the external Ca2+ dependence of the refilling
mechanisms. The store containing both RyR and Ins(1,4,5)P3R
may be positioned closer to the plasmalemma than that containing only
RyR and may be functionally more closely linked to Ca2+
entry via store-operated channels (63). Different isoforms of
SERCA, with different Ca2+ binding affinities,
e.g. K0.5 0.31 ± 0.02 µM and 0.17 ± 0.01 µM
Ca2+ for SERCA2a and SERCA2b, respectively (Ref. 42 for
review; see also Refs. 65-67), may be associated with the separate
stores and could explain the ability of the SR to refill in the
presence of different [Ca2+]c. Ca2+
uptake into stores by SERCA2b may also be modulated by calmodulin (68),
phospholamban (64, 67), and calreticulin and calnexin (26) so that
differential modulation of Ca2+ pumps may also help to
explain differences in store refilling in the absence of external
Ca2+.
The present study emphasizes the complexity of the organization of the
SR Ca2+ stores. It proposes the existence of two in the
control of Ca2+ release; one containing both RYR and
Ins(1,4,5)P3R and a second only RyR. The results also
highlight the possibility of structural components within the SR, each
with their unique content of receptors/channels permitting local
control of the SR Ca2+ signal in response to receptor modulation.
 |
ACKNOWLEDGEMENT |
We thank J. W. Craig for excellent
technical assistance.
 |
FOOTNOTES |
*
This work was funded in part by the Wellcome Trust
(0554328/Z/98/Z) and British Heart Foundation (PG/2001079).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Both authors contributed equally to this work.
§
A Caledonian Research Foundation Fellow. To whom correspondence
should be addressed: Tel.: 44-141-330-5143; Fax: 44-141-330-6610; E-mail: j.mccarron@bio.gla.ac.uk.
Published, JBC Papers in Press, July 26, 2001, DOI 10.1074/jbc.M104308200
 |
ABBREVIATIONS |
The abbreviations used are:
SR, sarcoplasmic
reticulum;
Ins(1, 4,5)P3, inositol 1,4,5-trisphosphate;
Ins(1, 4,5)P3R, Ins(1,4,5)P3 receptor;
RyR, ryanodine receptor;
CICR, Ca2+-induced Ca2+
release;
[Ca2+]c, cytosolic Ca2+
concentration;
SERCA, sarcoplasmic reticulum Ca2+ ATPase;
F/Fo, the ratio of fluorescence
counts (F) relative to baseline counts before stimulation
(Fo);
F/Fo, the magnitude of the change in F/Fo;
IBMX, 3-isobutyl-1-methylxanthine;
[cAMP]c, cytosolic
concentration of cAMP;
CPA, cyclopiazonic acid.
 |
REFERENCES |
| 1.
|
Somlyo, A. V.,
Bond, M.,
Somlyo, A. P.,
and Scarpa, A.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
5231-5235
|
| 2.
|
Nelson, M. T.,
Cheng, H.,
Rubart, M.,
Santana, L. F.,
Bonev, A. D.,
Knot, H. J.,
and Lederer, W. J.
(1995)
Science
270,
633-637
|
| 3.
|
Fasolato, C.,
Innocenti, B.,
and Pozzan, T.
(1994)
Trends Pharmacol. Sci.
15,
77-82
|
| 4.
|
Somlyo, A. P.
(1985)
Circ. Res.
57,
497-507
|
| 5.
|
Golovina, V. A.,
and Blaustein, M. P.
(1997)
Science
275,
1643-1648
|
| 6.
|
Lee, C.,
and Chen, L. B.
(1988)
Cell
54,
37-46
|
| 7.
|
Terasaki, M.,
and Jaffe, L. A.
(1991)
J. Cell Biol.
114,
929-940
|
| 8.
|
Yamamoto, A.,
Otsu, H.,
Yoshimori, T.,
Maeda, N.,
Mikoshiba, K.,
and Tashiro, Y.
(1991)
Cell Struct. Funct.
16,
419-432
|
| 9.
|
Takei, K.,
Mignery, G. A.,
Mugnaini, E.,
Sudhof, T. C.,
and De Camilli, P.
(1994)
Neuron
12,
327-342
|
| 10.
|
Montero, M.,
Alvarez, J.,
Scheenen, W. J. J.,
Rizzuto, R.,
and Meldolesi, J.
(1997)
J. Cell Biol.
139,
601-611
|
| 11.
|
Boittin, F. X.,
Macrez, N.,
Halet, G.,
and Mironneau, J.
(1999)
Am. J. Physiol.
277,
C139-C151
|
| 12.
|
Bolton, T. B.,
and Lim, S. P.
(1989)
J. Physiol. (Lond.)
409,
385-401
|
| 13.
|
Pacaud, P.,
and Loriand, G.
(1995)
J. Physiol. (Lond.)
484,
549-555
|
| 14.
|
Renzetti, L. M.,
Wang, M. B.,
and Ryan, J. P.
(1990)
Am. J. Physiol.
295,
G1-G5
|
| 15.
|
Wang, X.,
Lau, F.,
Li, L.,
Yoshikawa, A.,
and van Breemen, C.
(1995)
Circ. Res.
77,
37-42
|
| 16.
|
Janiak, R.,
Wilson, S. M.,
Montague, S.,
and Hume, J. R.
(2001)
Am. J. Physiol.
280,
C22-C33
|
| 17.
|
Young, S. H.,
Ennes, H. S.,
MacRoberts, J. A.,
Chaban, V. V.,
Dea, S. K.,
and Mayer, E. A.
(1999)
Am. J. Physiol.
276,
G1204-G1212
|
| 18.
|
Iino, M.,
Kobayashi, T.,
and Endo, M.
(1988)
Biochem. Biophys. Res. Commun.
152,
417-422
|
| 19.
|
Iino, M.
(1987)
Biochem. Biophys. Res. Commun.
142,
45-52
|
| 20.
|
Yamazawa, T.,
Iino, M.,
and Endo, M.
(1992)
FEBS Lett.
301,
181-184
|
| 21.
|
Baró, I.,
and Eisner, D. A.
(1995)
J. Physiol. (Lond.)
482,
247-258
|
| 22.
|
Tribe, R. M.,
Borin, M. L.,
and Blaustein, M. P.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
5908-5912
|
| 23.
|
Sugita, M.,
Tokutomi, N.,
Tokutomi, Y.,
Terasaki, H.,
and Nishi, K.
(1998)
Eur. J. Pharmacol.
348,
61-70
|
| 24.
|
Missiaen, L.,
Parys, J. B.,
De Smedt, H.,
Himpens, B.,
and Casteels, R.
(1994)
Biochem. J.
300,
81-84
|
| 25.
|
Bezprozvanny, I.,
Bezprozvanny, S.,
and Ehrlich, B. E.
(1994)
Mol. Biol. Cell
5,
97-103
|
| 26.
|
Roderick, H. L.,
Lechleiter, J. D.,
and Camacho, P.
(2000)
J. Cell Biol.
149,
1235-1248
|
| 27.
|
Komori, S.,
and Bolton, T. B.
(1989)
Br. J. Pharmacol.
97,
973-982
|
| 28.
|
Jaggar, J. H.,
and Nelson, M. T.
(2000)
Am. J. Physiol.
279,
C1528-C1539
|
| 29.
|
Schubert, R.,
Noack, T.,
and Serebryakov, V. N.
(1999)
Am. J. Physiol.
276,
C648-C658
|
| 30.
|
McCarron, J. G.,
and Muir, T. C.
(1999)
J. Physiol. (Lond.)
516,
149-161
|
| 31.
|
Cheng, H.,
Lederer, M. R.,
Lederer, W. J.,
and Cannell, M. B.
(1996)
Am. J. Physiol.
270,
C148-C159
|
| 32.
|
Trafford, A. W.,
Lipp, P.,
O'Neill, S. C.,
Niggli, E.,
and Einser, D. A.
(1995)
J. Physiol.
489,
319-326
|
| 33.
|
McCarron, J. G.,
Flynn, E. R. M.,
Bradley, K. N.,
and Muir, T. C.
(2000)
J. Physiol. (Lond.)
525,
113-124
|
| 34.
|
Butcher, T. W.,
and Sutherland, E. W.
(1962)
J. Biol. Chem.
237,
1244-1250
|
| 35.
|
Raeymaekers, L.,
Eggermont, J. A.,
Wuytack, F.,
and Casteels, R.
(1990)
Cell Calcium
11,
261-268
|
| 36.
|
Bian, J.,
Ghosh, T. K.,
Wang, J.-C.,
and Gill, D. L.
(1991)
J. Biol. Chem.
266,
8801-8806
|
| 37.
|
Robinson, I. M.,
and Burgoyne, R. D.
(1991)
J. Neurochem.
56,
1587-1593
|
| 38.
|
Khodakhan, K.,
and Armstrong, C. M.
(1997)
Biophys. J.
73,
3349-3357
|
| 39.
|
Cheek, T. R.,
Barry, V. A.,
Berridge, M. J.,
and Missiaen, L.
(1991)
Biochem. J.
275,
697-701
|
| 40.
|
Kanaide, H.,
Shogakiuchi, Y.,
and Nakamura, M.
(1987)
FEBS Lett.
214,
130-134
|
| 41.
|
Katsuyama, H.,
Ito, S.,
Ito, T.,
and Kuriyama, H.
(1991)
Pflugers Arch.
419,
460-446
|
| 42.
|
Missiaen, L.,
DeSmedt, H.,
Droogmans, G.,
DeClerck, I.,
Plessers, L.,
and Casteels, R.
(1991)
Biochem. Biophys. Res. Commun.
174,
1183-1188
|
| 43.
|
Robinson, I. M.,
and Burgoyne, R. D.
(1991)
FEBS Lett.
289,
151-154
|
| 44.
|
Tanaka, Y.,
and Tashjian, A. H., Jr.
(1993)
Biochem. J.
32,
12062-12073
|
| 45.
|
Yoshikawa, A.,
Van Breemen, C.,
and Isenberg, G.
(1996)
Am. J. Physiol.
271,
C833-C841
|
| 46.
|
Zacchetti, D.,
Clement, E.,
Fasolato, C.,
Lorenzon, P.,
Zottini, M.,
Grohovaz, F.,
Fumagalli, G.,
Pozzan, T.,
and Meldolesi, J.
(1991)
J. Biol. Chem.
266,
20152-20158
|
| 47.
|
Yu, M.,
Zhang, L.,
Rishi, A. K.,
Khadeer, M.,
Inesi, G.,
and Hussain, A.
(1998)
J. Biol. Chem.
273,
3542-3546
|
| 48.
|
Yu, M.,
Lin, J.,
Khadeer, M.,
Yeh, Y.,
Inesi, G.,
and Hussain, A.
(1999)
Arch. Biochem. Biophys.
362,
225-232
|
| 49.
|
Irvine, R. F.
(1990)
FEBS Lett.
263,
5-9
|
| 50.
|
Missiaen, L.,
Parys, J. B.,
DeSmedt, H.,
Oike, M.,
and Casteels, R.
(1994)
Mol. Cell. Endocrinol.
98,
147-156
|
| 51.
|
Hildalgo, C.,
and Donoso, P.
(1995)
Biosci Rep.
15,
387-397
|
| 52.
|
Sitsapesan, R.,
and Williams, A. J.
(1995)
J. Membr. Biol.
146,
133-144
|
| 53.
|
Combettes, L.,
Claret, M.,
and Champeil, P.
(1992)
FEBS Lett.
301,
287-290
|
| 54.
|
Beecroft, M. D.,
and Taylor, C. W.
(1997)
Biochem. J.
326,
215-220
|
| 55.
|
Missiaen, L.,
De Smedt, H.,
Parys, J. B.,
Van Acker, K.,
De Smet, P.,
and Callewaert, G.
(1999)
Biochem. Biophys. Res. Commun.
264,
967-971
|
| 56.
|
Parekh, A. B.,
and Penner, R.
(1997)
Physiol. Rev.
77,
901-930
|
| 57.
|
Lewis, R. S.
(1999)
Adv. Second Messenger Phosphoprotein Res
33,
279-307
|
| 58.
|
Putney, J. W.,
and Ribeiro, C. M. P.
(2000)
Cell. Mol. Life Sci.
57,
1272-1286
|
| 59.
|
Wayman, C. P.,
Gibson, A.,
and McFadzean, I.
(1998)
Pflugers Arch.
435,
231-239
|
| 60.
|
Bennett, D. L.,
Bootman, M. D.,
Berridge, M. J.,
and Cheek, T. R.
(1998)
Biochem. J.
329,
349-357
|
| 61.
|
Usachev, Y. M.,
and Thayer, S. A.
(1999)
J. Physiol. (Lond.)
519,
115-130
|
| 62.
|
Bennett, B.,
Sasajima, H.,
Wang, X. D.,
and VanBreemen, C.
(1997)
Biochem. Biophys. Res. Commun.
241,
471-475
|
| 63.
|
Golovina, V. A.,
and Blaustein, M. P.
(2000)
Glia
31,
15-28
|
| 64.
|
Eggermont, J. A.,
Wuytack, F.,
Verbist, J.,
and Casteels, R.
(1990)
Biochem. J.
271,
649-653
|
| 65.
|
Misquitta, C. M.,
Mack, D. P.,
and Grover, A. K.
(1999)
Cell Calcium
25,
277-290
|
| 66.
|
Shull, G. E.
(2000)
Eur. J. Biochem.
267,
5284-5290
|
| 67.
|
Verboomen, H.,
Wuytack, F.,
De Smedt, H.,
Himpens, B.,
and Casteels, R.
(1992)
Biochem. J.
286,
591-595
|
| 68.
|
Grover, A. K.,
Xu, A.,
Samson, S. E.,
and Narayanan, N.
(1996)
Am. J. Physiol.
271,
C181-C187
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
A. Edwards and T. L. Pallone
Mechanisms underlying angiotensin II-induced calcium oscillations
Am J Physiol Renal Physiol,
August 1, 2008;
295(2):
F568 - F584.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. McCarron and M. L. Olson
A Single Luminally Continuous Sarcoplasmic Reticulum with Apparently Separate Ca2+ Stores in Smooth Muscle
J. Biol. Chem.,
March 14, 2008;
283(11):
7206 - 7218.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. McCarron, S. Chalmers, and T. C. Muir
`Quantal' Ca2+ release at the cytoplasmic aspect of the Ins(1,4,5)P3R channel in smooth muscle
J. Cell Sci.,
January 1, 2008;
121(1):
86 - 98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. Kovac, T. Chrones, and S. M. Sims
Temporal and spatial dynamics underlying capacitative calcium entry in human colonic smooth muscle
Am J Physiol Gastrointest Liver Physiol,
January 1, 2008;
294(1):
G88 - G98.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. R. H. Mauban, K. Wilkinson, C. Schach, and J. X.-J. Yuan
Histamine-mediated increases in cytosolic [Ca2+] involve different mechanisms in human pulmonary artery smooth muscle and endothelial cells
Am J Physiol Cell Physiol,
February 1, 2006;
290(2):
C325 - C336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Morimura, Y. Ohi, H. Yamamura, S. Ohya, K. Muraki, and Y. Imaizumi
Two-step Ca2+ intracellular release underlies excitation-contraction coupling in mouse urinary bladder myocytes
Am J Physiol Cell Physiol,
February 1, 2006;
290(2):
C388 - C403.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. MacMillan, S. Currie, K. N. Bradley, T. C. Muir, and J. G. McCarron
In smooth muscle, FK506-binding protein modulates IP3 receptor-evoked Ca2+ release by mTOR and calcineurin
J. Cell Sci.,
December 1, 2005;
118(23):
5443 - 5451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. MacMillan, S. Chalmers, T. C. Muir, and J. G. McCarron
IP3-mediated Ca2+ increases do not involve the ryanodine receptor, but ryanodine receptor antagonists reduce IP3-mediated Ca2+ increases in guinea-pig colonic smooth muscle cells
J. Physiol.,
December 1, 2005;
569(2):
533 - 544.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Cao, C. Fiocchi, and V. E. Pricolo
Production of IL-1{beta}, hydrogen peroxide, and nitric oxide by colonic mucosa decreases sigmoid smooth muscle contractility in ulcerative colitis
Am J Physiol Cell Physiol,
December 1, 2005;
289(6):
C1408 - C1416.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Cao, K. M. Harnett, L. Cheng, M. T. Kirber, J. Behar, and P. Biancani
H2O2: a mediator of esophagitis-induced damage to calcium-release mechanisms in cat lower esophageal sphincter
Am J Physiol Gastrointest Liver Physiol,
June 1, 2005;
288(6):
G1170 - G1178.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-M. Zheng, Q.-S. Wang, R. Rathore, W.-H. Zhang, J. E. Mazurkiewicz, V. Sorrentino, H. A. Singer, M. I. Kotlikoff, and Y.-X. Wang
Type-3 Ryanodine Receptors Mediate Hypoxia-, but Not Neurotransmitter-induced Calcium Release and Contraction in Pulmonary Artery Smooth Muscle Cells
J. Gen. Physiol.,
March 28, 2005;
125(4):
427 - 440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Morales, P. J. Camello, G. M. Mawe, and M. J. Pozo
Characterization of intracellular Ca2+ stores in gallbladder smooth muscle
Am J Physiol Gastrointest Liver Physiol,
March 1, 2005;
288(3):
G507 - G513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Laporte, A. Hui, and I. Laher
Pharmacological Modulation of Sarcoplasmic Reticulum Function in Smooth Muscle
Pharmacol. Rev.,
December 1, 2004;
56(4):
439 - 513.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Cao, M. D. Vrees, F. M. Potenti, K. M. Harnett, C. Fiocchi, and V. E. Pricolo
Interleukin 1{beta}-Induced Production of H2O2 Contributes to Reduced Sigmoid Colonic Circular Smooth Muscle Contractility in Ulcerative Colitis
J. Pharmacol. Exp. Ther.,
October 1, 2004;
311(1):
60 - 70.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. McCarron, K. N. Bradley, D. MacMillan, S. Chalmers, and T. C. Muir
The Sarcoplasmic Reticulum, Ca2+ Trapping, and Wave Mechanisms in Smooth Muscle
Physiology,
June 1, 2004;
19(3):
138 - 147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. McCarron, D. MacMillan, K. N. Bradley, S. Chalmers, and T. C. Muir
Origin and Mechanisms of Ca2+ Waves in Smooth Muscle as Revealed by Localized Photolysis of Caged Inositol 1,4,5-Trisphosphate
J. Biol. Chem.,
February 27, 2004;
279(9):
8417 - 8427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. N. Bradley, S. Currie, D. MacMillan, T. C. Muir, and J. G. McCarron
Cyclic ADP-ribose increases Ca2+ removal in smooth muscle
J. Cell Sci.,
November 1, 2003;
116(21):
4291 - 4306.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Ohya and B. Horowitz
Differential transcriptional expression of Ca2+ BP superfamilies in murine gastrointestinal smooth muscles
Am J Physiol Gastrointest Liver Physiol,
December 1, 2002;
283(6):
G1290 - G1297.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. White and J G. McGeown
Carbachol triggers RyR-dependent Ca2+ release via activation of IP3 receptors in isolated rat gastric myocytes
J. Physiol.,
August 1, 2002;
542(3):
725 - 733.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D V Gordienko and T B Bolton
Crosstalk between ryanodine receptors and IP3 receptors as a factor shaping spontaneous Ca2+-release events in rabbit portal vein myocytes
J. Physiol.,
August 1, 2002;
542(3):
743 - 762.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. McCarron, J. W. Craig, K. N. Bradley, and T. C. Muir
Agonist-induced phasic and tonic responses in smooth muscle are mediated by InsP3
J. Cell Sci.,
May 15, 2002;
115(10):
2207 - 2218.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|